Neutrophils Response to Human CMV Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

被引：0
|
作者：
Costa, Martina [1 ]
Tamassia, Nicola [1 ]
Ligozzi, Marco [1 ]
Marini, Olivia [1 ]
Cassatella, Marco [1 ]
Tecchio, Cristina [1 ]
机构：
[1] Univ Verona, Verona, Italy
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P392
引用
下载
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [21] Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
    John, Tami
    Neudorf, Steven
    Kirov, Ivan
    Ashouri, Negar
    Van Huynh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S226 - S227
  • [22] Primary care for allogeneic hematopoietic stem cell transplant recipients
    Fulcher, Jill
    Hertz, Sherrie
    Bredeson, Christopher
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (06) : E225 - E226
  • [23] Iron Overload in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Ali, Sharif
    Pimentel, Jason D.
    Munoz, Javier
    Shah, Veena
    McKinnon, Rick
    Divine, George
    Janakiraman, Nalini
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (05) : 532 - 538
  • [24] Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients
    Cheplowitz, Halle
    Patel, Nimish
    Kim, Alexander
    Logan, Cathy
    Law, Nancy
    Koura, Divya
    Haste, Nina
    Medley, Katherine
    Trinh, Julie
    Sanders, Tyler
    Taremi, Mahnaz
    Saunders, Ila M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (01) : 15 - 18
  • [25] HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant
    Ghobadia, Armin
    Milton, Denai R.
    Gowda, Lohith
    Rondon, Gabriela
    Chemaly, Roy F.
    Hamdi, Amir
    Alousi, Amin
    Afrough, Aimaz
    Oran, Betul
    Ciurea, Stefan
    Kebriaei, Partow
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Bashir, Qaiser
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2019, 67 (02) : 51 - 55
  • [26] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7
  • [27] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
  • [28] THE EFFECT OF DONOR CMV SEROSTATUS ON CMV INFECTION AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS
    Green, J. S.
    Mulroney, C. M.
    Curtin, P. T.
    Taplitz, R. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S234 - S235
  • [29] EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes
    Law, Nancy
    Logan, Cathy
    Taplitz, Randy
    VIRUSES-BASEL, 2024, 16 (08):
  • [30] Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
    Merchant, Shelby Lorraine
    Gatwood, Katie S.
    Satyanarayana, Gowri
    Byrne, Michael T.
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin
    Engelhardt, Brian G.
    Culos, Kathryn Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345